wane. Therefore, immunization with epidermal cells conjugated with antigen induces a class of CS more like the one induced by skin painting than like the one induced by injection of antigen-conjugated PEC. Thus, not only the anatomical site where antigen is first encountered by the immune apparatus, but also the nature of the cells that present the antigen, determine whether a DTH response will ensue, as well as whether it will be evanescent or long-lasting.
Materials and Methods
Animals. Inbred CBA mice of both sexes, weighing 22-25 g were used in all experiments.
Only one sex was used in any one experiment. These mice and BALB/c mice were obtained from the breeding unit of the Institute of Microbiology, Cracow, Poland. Guinea pigs were purchased from a local supplier in Poland.
Reagents. The following reagents were used: picryl chloride (PCL) (Fluka AG, Buchs, Switzerland); trinitrobenzene sulphonic acid (PSA) and oxazolone (OX) (4-ethoxymethylene-2-phenyloxazolone) (British Drug Houses Ltd., Poole, Dorset, England); [51Cr]sodium chromate (Institute for Nuclear Research, Warsaw, Poland); and CY (VEB, Jenapharm, Democratic Republic of Germany).
Cells
MACROPHAGES. Peritoneal exudates were induced by i.p. injection of 3 ml of thioglycollate medium (Difco Laboratories, Detroit, Mich.) or 3 ml Marcol 52 oil (Exxon Corp., New York). The cells harvested 4 or 5 d later, respectively, were 90-95% macrophages and were termed PEC throughout.
TIJVMOCVTES. Thymuses were removed after exsanguination and were gently teased apart between the frosted ends of microscope slides into the cold Hanks' balanced salt solution (HBSS).
EPIDERMAL CELLS. Epidermal cells were obtained from the tail skin by trypsinization according to the method of Scheid et al. (4) with minor modifications. In one experiment, epidermal cells were separated into fractions enriched and depleted of Fc-positive cells. Epidermal cells were incubated (37°C, 45 rain) with SRBC coated with mouse anti-SRBC antibody at a ratio of 10 SRBC:epidermal cells, and then were layered over Ficoll (Pbarmacia Fine Chemicals, Div. of Pharmacia, Inc., Piscataway, N. J.)-sodium metrizoate (12 parts 14% Ficoll 400 + 5 parts 32.8% sodium metrizoate) and centrifuged for 30 rain at 2,000 g. Cells from the overlayer and pellet were freed of erythrocytes by treatment with 0.17 M NH4CI, labeled with trinitrophenyl (TNP), and injected intravenously into CBA mice. The pellet fraction contained 18% of the skin cells and was called Fc enriched, whereas the overlayer was called Fc depleted.
ERVTnROCV'rES. Mouse erythrocytes (MRBC) were collected after injection of 200 U heparin i.v. per mouse. Before hapten labeling, the buffy coat was removed. Chicken erythrocytes (CRBC) were a mixture obtained from three donors. SRBC were obtained from a single animal.
Hapten Labeling of Cells. All cells were washed several times in HBSS before they were labeled with hapten. TNP-substituted erythrocytes were prepared as described by Rittenberg and Pratt (5) with minor modifications (6) . 20 mg of PSA per 7 ml of cacodylate buffer were used to label 1 ml of packed erythrocytes. PSA in HBSS (3 mg/ml) was used to label 5 × 10 v nucleated cells for 10 min at room temperature. OX was dissolved in absolute ethanol (10 mg/ ml) and mixed rapidly with 20 ml of EDTA buffer (0.05 M, pH 8.4). The solution was used immediately for cell labeling (7). 1 ml of packed MRBC was suspended in 10 ml calcium-free HBSS and mixed with 20 ml of OX solution. Nucleated cells were suspended in HBSS at 107/ ml and mixed with a double volume of OX solution diluted previously 1 : 1 with EDTA buffer. PEC and thymocytes were labeled for 10 min at room temperature, whereas MRBC were labeled for 30 min. After labeling, cells were washed twice with EDTA buffer (0.05 M, pH 7.5), once with HBSS, then were filtered through nylon N110 gauze, and the cell density was adjusted to the desired concentration. Viability was assessed by trypan blue dye exclusion and ranged between 70 and 85%. Generally, ~50% of the cells were recovered after hapten conjugation.
Antibodies. CBA mice were injected three times at weekly intervals with 5 × 10 s TNPsubstituted CRBC (TNP-CRBC), and bled out 7 d after the last injection. The hemagglutination titer of the pooled sera was 1:1,024 with TNP-substituted SRBC. Guinea pigs were injected with 109 MRBC, 108 thymocytes, or 5 × 108 TNP-CRBC i.v. at two occasions 2 wk apart and bled out 6 d later. Anti-MRBC and anti-thymocyte antibody were adsorbed (1:1) with thymocytes or MRBC, respectively, and no cross-reactions were found in hemagglutination. The hemagglutination titers of adsorbed guinea pig anti-MRBC and anti-TNP sera were 1:1,024 and 1:512, respectively. Anti-thymocyte serum diluted 1:40 killed 10 v thymocytes per ml in the presence of complement. Sera were heat inactivated at 56°C for 30 rain before being used.
Preparation of (Fab')~ Fragments. The IgG-containing fraction of anti-TNP antibody in guinea pig immune serum was precipitated three times with 33% saturated NH4SO4. Pepsin digestion was performed as described elsewhere (8) . The digested globulin fraction was dialyzed into 0.1 M phosphate buffer, pH 6.8, and was applied to a 2-X 60-cm Sephadex G-100 column (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.). Protein concentration in each fraction was estimated spectrophotometrically at 280 nm, and the hemagglutination titer of each fraction was determined. Fractions showing the peak values were pooled and concentrated by ultrafiltration. The hemagglutination titer of the (Fab')2 preparation was 1:320.
Coating of TNP-substituted Cells with Antibody. TNP-labeled cells were incubated for 45 min at room temperature with antibody directed against the hapten or the cell to which the TNP was attached. As a routine procedure, 1 × 108 cells were incubated with 1 ml of corresponding antibody diluted 1:10.
Feeding of PEC with Antzgen. Thioglycollate-induced PEC were incubated in vitro for 45 min at 37°C in the presence of ~lCr-labeled TNP-substituted MRBC (TNP-MRBC) coated with either anti-MRBC or anti-TNP antibody, at a PEC to erythrocyte ratio of 1:10. After incubation, the mixture was washed, nonphagocytosed erythrocytes were lysed with 0.17 M NH4C1 buffer, the remaining cells were washed several times in HBSS, counted in well-type gamma counter (Beckman Instruments, Munich, Federal Republic of Germany) and injected intravenously into recipients within 1 h.
Sensitization to PCL or OX. Mice were sensitized by applying 0.15 ml of a 7% solution of PCL or 3% OX in absolute ethanol to the skin of the clipped abdomen. 4 d later, unless otherwise state, control ear thickness was measured with an engineer's micrometer (Moore and Wright, Sheffield, England), then both sides of both ears were painted with a 1% solution of homologous contact reagent dissolved in olive oil, and the increment of ear thickness was measured 24 h later. Results were expressed as the mean + SD in units of 10 -3 cm (9).
Induction of CS Immunity or
Unresponsiveness by Cell-bound Hapten. CBA mice were injected with hapten-substituted syngeneic or allogeneic cells intravenously, subcutaneously, intraperitoneally, or into the footpad. Routinely (unless otherwise state), 3 × 10 6 epidermal cells, 5 X 10 6 PEC, 5 × 10 7 thymocytes (Thy), or 109 MRBC were injected. Some mice were treated with 50 mg/kg CY i.p. 24 h before injection of hapten-substituted cells.
Mice were tested for CS 7 d after the cell injection (unless otherwise stated), because it was found that they develop peak responses at this time. Mice found to be unresponsive were contact painted with corresponding or unrelated skin sensitizer and were tested 4 d later to ascertain if the unresponsiveness was the result of specific tolerance. Experiments in which ear swelling was measured at 12, 24, and 48 h showed that the peak response occurred 24 h after challenge in both skin-sensitized mice and those immunized with hapten-conjugated cells. Thus, only 24-h responses are shown in the Tables.
As a result of normal inter-experimental variability of ear swelling induced by contact painting in both sensitized and nonsensitized normal controls, the results were shown as the percentage of CS responses of contact-sensitized positive controls when data was summarized from several experiments. These were calculated for each individual experimental group according to the formula: the percentage of CS response = (A -C)/(B -C) x 100; where A refers to the 24-h increment in ear thickness in an experimental group that was immunized with conjugated cells; B refers to the 24-h increment in ear thickness in a positive control group which was immunized by contact skin painting; and C refers to the nonspecific 24-h increment in ear thickness of nonimmune controls. (Table I) . Hapten-conjugated PEC injected intravenously or intraperitoneally failed to induce CS, but when similar numbers of TNP-substituted (TNP-PEC) or OX-substituted PEC were injected subcutaneously (into the scapular region or into the footpads) mice had significant CS 1 wk later. The CS induced in this manner was hapten-specific (results not shown). Oil-induced syngeneic TNP-PEC were more immunogenic than thioglycollate-induced cells (group A vs. B) and allogneic conjugated PECI did not induce CS (group C). TNP-substituted Thy (TNP-Thy) used in similar numbers as PEC (group D) induced insignificant CS, whereas higher numbers (group E) were moderately immunogenic. Thus, the induction of CS with haptenconjugated PEC depends largely on the route of injection and the use of syngeneic cells.
Results

Induction of Immunity or Unresponsiveness by PEC-bound Hapten, According to the Route of Injection
Induction of Specific Unresponsiveness by Cell-bound
Hapten. Experiments were conducted to see if the failure to induce CS by intravenous or intraperitoneal injection of hapten-conjugated cells was a result of the induction of tolerance. The results of such an experiment (Table II) show that mice injected intravenously with syngeneic or allogeneic PEC, Thy or erythrocytes labeled with TNP or OX could not be skin sensitized with appropriate sensitizer 7 d after injection of these cells. Unresponsiveness was specific because only responses to the homologous hapten were inhibited (Table  II) . However, suppression was less significant when OX was used to label the cells. Thus, neither the source of cells nor their genetic makeup was relevant to inducing specific unresponsiveness. (Table III) The Table shows the combined results of four independent experiments in .which each experimental group consisted of four to six animals. * TNP-substituted syngeneic or atlogeneic cells were injected intravenously into normal or CY-treated animals (50 mg/kg, 24 h before cell injection) and CS was tested 7 d later.
Effect of CY on the Induction of CS
Results are expressed as the percentage of CS responses + SD of contact skin-sensitized positive controls. The Table shows the combined results from three independent experiments in which each experimental group consisted of" five or six animals.
numbers induced some CS in CY-pretreated mice (groups C, D, and E). The CS was specific in that no increase in ear thickness occurred after challenge with OX, a noncross-reacting hapten (Results not shown.). Thus, CY-sensitive regulatory cells were involved in the induction of tolerance by intravenous injection of hapten-conjugated syngeneic cells. (Table IV) . Injection of TNP-substituted cells intravenously does not cause the development of CS, but when the TNP-substituted cells were treated with antibody directed against TNP or against the cell to which the TNP was attached, significant CS could be induced. The reaction induced by antibody-treated TNP-substituted cells was specific in that no responses 
Influence of Antibody on the Induction of CS by Cell-bound TNP
Induction of CS by PEC That Had Phagocytosed Opsonized TNP-conjugated Erythrocytes
In vitro cell combination before intravenous injection* CS at 7 d (Table V) . When PEC were combined in vitro with TNP-MRBC which were complexed with antibody directed against TNP or MRBC, and were then freed of erythrocytes and injected invtravenously, they induced a significant level of CS. Thus, there is a substantial difference between PEC that were conjugated directly with TNP, and those that had ingested TNP antigen; only the latter were able to induce CS upon intravenous injection. These results also support the conclusion that antibody treatments (Table  IV) allow induction of CS by promoting phagocytosis of the antigen. (Table VI) . In contrast to the other cell types conjugated with hapten that, when injected intravenously, induced a state of unresponsiveness, TNP-or OX-conjugated epidermal cells injected intravenously induced CS. Conjugated epidermal cells had to be syngeneic with the recipient to induce CS. TNP-conjugated epidermal cells (TNP-epidermal cells) were also immunogenic when injected intraperitoneally or subcutaneously. Furthermore, TNP-epidermal ceils induced CS even when injected intravenously with doses of TNP-PEC that induce tolerance. Thus, hapten-conjugated epidermal cells failed to suppress CS and uniformly induced CS, independent of the route of injection, and even when coadministered with doses of TNP-PEC that by themselves induced unresponsiveness. Epidermal cells were fractionated by taking advantage of the fact that some of these cells (i.e., Langerhans cells [10] ) have Fc receptors that promote adherence and rosette formation. Accordingly, epidermal cells were incubated with SRBC coated with mouse antibody and then were centrifuged in a Ficoll-Hypaque (Winthrop Laboratories, New York) gradient. The pellet contained 18% of the epidermal cells and was called Fc enriched, whereas the remaining cells at the interface were called Fc depleted. After erythrocyte lysis, both populations were conjugated with TNP and were used to induce CS by intravenous injection. The results of such an experiment (Table VII) 
Induction of CS by PEC that Phagocytosed TNP-substituted Cells
Induction of CS by Hapten Bound to Epidermal Cells
Passive Transfer of CS Induced by Different Schedules. The experiments presented above
showed that a similar CS could be induced by skin painting with PCL, by subcutaneous injection of TNP-PEC, by intravenous injection of TNP-Thy complexed with antibody, and by intravenous injection of TNP-conjugated epidermal cells. To confirm that in all cases we were dealing with a simi|ar cell-mediated phenomenon, adoptive transfer experiments were performed. As shown in Table VIII , all of these modes of induction of CS provided sensitized cells which could transfer the ability to mount specific CS reactions to naive recipients, thus showing that a similar mechanism was involved in all cases. (Fig. 1) . CS reactions developed within 3-4 d in PCL contact skin-sensitized animals. By day 5 after PCL painting, maximal CS was elicited, and was equally elicitable over the next 10 d. In contrast, CS induced by TNP-PEC injected subcutaneously, or by intravenous TNP-Thy coated with anti-TNP antibody, was not maximal until 6-8 d, and then progressively declined; approaching responses in nonimmune animals by day 15. On the o.ther hand, although CS induced by injection of TNP-epidermal cells also did not reach a maximum until day 6-8, they did not decline and therefore resembled in their lack of evanescence the CS induced by contact skin painting. Thus, contact painting or injection of TNP-epidermal cells induced CS that was long-lived, whereas TNP-PEC, or antibody-coated TNP-Thy, induced CS that was evanescent.
Time-Course of Elicited CS Induced by Different Modes of Immunization
Discussion
In this study, we have described three major outcomes of immunization with various forms of TNP: the induction of specific immunological unresponsiveness (tolerance) for CS, the induction of a short-lived or evanescent form of CS, or the induction of a long-lived form of CS.
The first outcome, the induction of specific immunological unresponsiveness, is probably the result of educating a net excess of suppressor cells that inhibits animals from making a CS immune response, and also makes them resistant to further immunization. As has been noted previously (3, 11) , this occurs when initial immunization with TNP-conjugated cells occurs in the spleen via intravenous injection of hapten-conjugated ceils. There is no requirement for major histocompatibility complex (MHC) identity between the haptenated cells and the host for this form of specific immunosuppression to occur, and presentation need not be on macrophages. However, we have found two ways to overcome this suppression: (a) allowing phagocytosis of antigen to occur or (b) by using TNP-conjugated epidermal cells (see below).
The second outcome, induction of evanescent CS with an early peak followed by a rapid decline, occurs when the balance between suppression and helpers is skewed toward the latter situation by reduced activation of the suppressor circuit. There are three major ways to favor this skewing: (a) Pretreat the animals with a low dose of CY before their initial contact with antigen. CY, in the dose used, has been shown to inhibit cells in the suppressor T-cell circuit (11, 12) . Our results in this case contrast with the findings of Miller et al. (13) . Using a different hapten (dinitrophenyl), these authors found that pretreatment with CY at a much higher dose than we used (200 mg/kg) did not allow intravenously injected haptenated cells to induce immunity. The many differences between their experimental protocol and ours makes it difficult to identify the variable(s) that might account for the different results. However, because we (Table III) it from fulfilling its role in inhibiting suppression, and feeding macrophages antigen before using them as immunogens also blocks their suppressor inducing qualities after intravenous injection. Once the antigen has undergone phagocytosis by macrophages, the antigen may be processed in a way which inhibits its ability to activate the suppressor circuit (perhaps as a result of antigen degradation as the work of Steinman and Cohn [14] has suggested) or favors induction of T cells which elicit DTH, as the work of Zembala et al. (15) has suggested. The conclusion that the host is processing antigen is supported by the observation that antibody coating of the TNP-conjugated cells is the only mode of sensitization in which TNP does not have to be syngeneic with the host to induce immunity. Presumably, after phagocytosis the antigen is presented to the immune system in association with the major histocompatibility determinants of the host's antigen-presenting cells. (ii) Antibody may alter the distribution of antigen within the lymphoid organs so that immunogenicity is enhanced and/or suppression reduced. An example of the latter is the retention of antigen-antibody complexes in the germinal center region of lymphoid organs. Chen et al. (16) , using horseradish peroxidase (HRP) as a marker, have shown that small amounts of HRP-anti-HRP immune complexes formed in antigen excess escape phagocytosis and instead associate with the cell surface of nonphagocytic follicular dendritic cells~ In this regard it is important to note that we have found that the mQst effective antigen presentation is performed by cells that are weakly phagocytic (Langerhans cells) or nonphagocytic (splenic dendritic cells, vide lhfra). (c) A third way of eliciting short-lived CS is by injecting the antigen-conjugated cells, that are predominantly macrophages, in such a way that primary immunization occurs in peripheral lymph nodes (3) . This technique probably also works via bypassing suppression because it is well known that spleen-localizing T cells are much more likely to induce or act as suppressor cells than are cells that localize in the lymph node (17) .
As noted by Greene et al. (3) there is a clear-cut hierarchy in the ability of different types of cells to immunize under those conditions which bypass suppression; PEC being significantly superior to Thy which are somewhat better than erythrocytes. It is unclear whether CY or antibody treatment blocks the suppression elicited by TNPconjugated allogeneic cells, because MHC-incompatible cells fail to immunize. Thus, no reaction would be detected even if suppression had been alleviated.
The third outcome which may occur after immunization with TNP is the induction of a relatively long-lived form of immunity. This occurs after skin painting or more interestingly, when haptenated epidermal cells are injected intravenously. Under these circumstances there is no need for blockage of the suppressor circuit for immunity to be seen. Whether the responses induced by this mechanism would be further augmented if suppression were to be reduced is now being tested.
The cell type(s) in the skin which are responsible for this potent form of antigen presentation are most likely Langerhans cells, because many of them appear to have Fc receptors (10) . That the apparently Fc-negative skin cells can also induce this type of immunity, although less well than the Fc-positive fraction of cells, may be a result of contamination of the Fc-negative fraction, or skin cells themselves may have the ability to present hapten. This latter possibility is rendered unlikely because we have found that the epidermal cell type responsible for inducing long-lived CS bears surface antigens coded by the I region of the MHC. (a) Within the PEC population there is a cell with an inducing quality similar to Langerhans cells but that their activity is not seen because of the fact that they are present only in very small numbers. The particular type of cells we have in mind would be a minimally phagocytic macrophage-like cell with cell surface antigens, coded for in the I region of the MHC (20, 21) . Thus, we are trying to concentrate Iapositive cells from various anatomical compartments to see if they have the same inducing qualities as do Langerhans cells.
One such cell is the splenic dendritic cell described by Steinman et al. (22) . These cells are adherent and Ia positive, but lack Fc receptors and constitute < 1% of splenic cells. Preliminary results indicate that enriched, TNP-conjugated splenic dendritic cells are able to function as potent antigen-presenting cells that can mimic Langerhans cells in their capacity to induce CS, even when injected intravenously, whereas enriched Fc-positive splenic macrophages that are conjugated with TNP mimic PEC macrophages in their inability to induce CS (W. Ptak and R. Steinman. Unpublished Results.).
(b) It is also possible that not all Ia-positive cells are the same, and that the Iapositive cells in the skin will be different from Ia-positive antigen-presenting cells which are found in other anatomical compartments. If this proves to be the case, it would then be interesting and important to see if non-skin cells can be induced to behave like skin cells by things other than the dermal-epidermal microenvironment. In particular, we have preliminary evidence that macrophages, stimulated by adjuvants that contain mycobacteria can acquire the immunity-inducing capacities of skin cells. The notion that this idea might be feasible, stems from the observations that (i) immunization with complete Freund's adjuvant leads to a long-lived immunity (2) and (ii) the studies of delayed type hypersensitivity by Mackaness et al. (2) It is also important to determine why some modes of antigen presentation can induce immunity without the need for inhibition or bypassing of the suppressor circuit. Because TNP-epidermal cells are able to induce CS when injected intravenously mixed with TNP-PEC, this implies that Langerhans cells can effectively present antigen in the presence of suppression, whereas immunity-inducing, antigenpresenting cells in PEC cannot. This might suggest that Langerhans cells are able to activate effector T cells that are relatively resistant to suppression, or alternatively, that the specialness of these antigen-presenting cells is their inability to interact with the cells of the suppressor circuit.
In any case, it is quite interesting to note that CS comes in the same two forms as other forms of DTH and that the type of immunity which will evolve depends upon a complex interplay between three major classes of cell types: the antigen-presenting cells, the DTH effector cells, and the cells in the regulatory suppressor cell circuit (24) . The three major factors that have been identified so far which can significantly alter the normal interplay are: (a) the anatomical site where the initial immunizing procedure occurs; (b) the presence or absence of a subset of cells in the suppressor circuit that are highly sensitive to CY; and (c) the nature and origin of the cell which presents the antigen.
Summary
Three outcomes pertinent to contact sensitivity (CS) follow immunization with various forms of trinitrophenylated (TNP) substrates: (a) specific immunological unresponsiveness for CS is induced when immunization favors activation of splenic suppressor cells. This state is achieved by intravenous injection of trinitrophenylconjugated to various types of cells, such as peritoneal exudate cells (PEC). (b) A short-lived or evanescent form of CS is induced when immunization reduces activation of the suppressor circuit. This can be achieved by subcutaneous immunization with trinitrophenyl conjugated to syngeneic PEC, by pretreatment with cyclophosphamide to diminish suppression before intravenous immunization, or by altering the mode of antigen presentation by using TNP-substrate that has undergone phagocytosis. (c) A long-lived form of CS is induced when trinitrophenyl is presented to the immune system on skin cells either by contact skin painting with reactive trinitrophenyl, or by subcutaneous, or even intravenous injection of trinitrophenyl-conjugated epidermal cells. In fact, trinitrophenyl-conjugated epidermal cells induced CS even when the suppressor circuit was activated by intravenous coadministration of TNP-PEC. This implies that antigen presentation on epidermal cells induces sensitized cells that are relatively resistant to suppression. The cell type(s) in the skin that are primarily responsible for this potent form of antigen presentation are most likely Langerhans cells, because they can be concentrated by virtue of their Fc receptors and they are Ia positive. Thus, both the anatomical site where antigen is first encountered by the immune apparatus, as well as the nature of the cells which present the antigen, determine whether a CS response will ensue, as well as whether it will be evanescent or long-lasting.
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